News
Dynavax posts 2Q loss, weighed down by expenses (AP)
July 30, 2010 by · Leave a Comment
AP – Drug developer Dynavax Technologies Corp. said Friday that higher operating expenses, weak revenue and costs linked to a stock offering drove it to a second-quarter loss, reversing a year-ago profit.
Read the original post:
Dynavax posts 2Q loss, weighed down by expenses
(AP)